Creation principles and linguistic characteristics
Commercial drug brands are created empirically by pharmaceutical manufacturers, i.e., arbitrarily. The main goal of such a name is successful sales and brand recognition. For a drug to be registered, its name must meet several strict requirements.
First, it must not coincide with names already in circulation. Second, the new word must differ fundamentally in its external phonetic and graphic appearance from analogues. Third, short forms are preferred. Linguistically, such terms represent neologism words. When creating them, authors usually do not embed explicit signs of semantic motivation, which is why they appear to physicians as new, artificially constructed lexical units.
Signs of motivation in names
Despite the abundance of unmotivated neologisms, three groups of drugs whose names retain a semantic connection can be distinguished in pharmaceutical terminology.
- Anatomical or physiological nature. Include roots indicating an organ or process: Venitan (from Lat. vena — vein), Pulmex (from Lat. pulmo — lung), Corgard (from Lat. cor — heart), Prododerm (from Greek derma — skin), Febichol (from Greek chole — bile), Uracton (from Greek uron — urine).
- Pharmacotherapeutic action. Reflect the therapeutic effect: antihypertensive Tensidomin (from Lat. tensio — pressure), anticoagulant Antithrombinum (from Greek thrombos — clot), laxative Laxatin (from Lat. laxativum), antifungal Funginal (from Lat. fungus — fungus), estrogen preparations Orto-gynest (from Greek gyne — woman) and Ovestin (from Lat. ovum — egg).
- Source of origin. They indicate animal or plant raw materials: Senade is made from senna (Senna), Vincapanum from periwinkle alkaloids (Vinca), Thymolinum from the thymus gland (thymus), Spleninum from the spleen (splen), and Apilacum contains royal jelly (from Lat. apis — bee and lac — milk).
Unmotivated words and abbreviations
A huge layer of commercial nomenclature consists of words that do not carry a clear semantic load. As a rule, they hint at the synthetic chemical origin of the substance. Pharmacists take the original chemical name and create a compound-shortened word (abbreviation) from it through an arbitrary combination or rearrangement of syllables.
| Original chemical name | Trade name | Note (etymology) |
|---|---|---|
| 1,2-diphenyl-4-butyl-pyrazolidinedione-3,5 | Butadionum | Compound-shortened word |
| 2-benzylbenzimidazole hydrochloride | Dibazolum | From Greek di — 2 |
| 4-methyl-5-oxomethyluracil | Pentoxylum | From Greek penta — 5 |
Such names often contain repeating sound complexes — frequency segments. They may conceal anatomical or therapeutic information and act as term elements.
Relationship between INNs and commercial brands
The same active substance, having a single International Nonproprietary Name (INN), can be sold under dozens of different commercial synonyms. For example, the INN Diclofenacum is available in pharmacies as Bioran, Veral, Votrex, Olfen or Feloran. Another example is Nifedipinum, which is marketed under the brands Adalat, Nifelat, Gipernal i Zenusin. The patented brand name is always marked with the symbol ® in superscript (for example, Cavinton®).
Briefly: answers to topical questions
How should trade names of medicinal products be written in the Latin part of a prescription?
Trade names of medicinal products in the Latin part of a prescription are written in quotation marks. In the prescription line, such a combined name is written in the nominative case (Nominativus) and is usually not declined.
To memorize the principles of semantic motivation, use the "AES" rule: Organ (Venitan), Effect (Laxatin), Source (Apilacum).
Class and exam questions
How does a brand name differ from an INN?
A trade name is invented and patented by a specific pharmaceutical company to sell the finished drug. INN is the universal international nonproprietary name of the active substance itself.
What does the ® symbol after a drug name mean?
This icon indicates that the brand name of the original drug is officially patented and has the legal status of a trademark.
Can organ names be used when creating new drugs?
According to modern principles for creating International Nonproprietary Names, the use of anatomical and physiological roots for naming new drugs is not recommended.
What else to study on this topic
- Frequency segments and their meanings in pharmaceutical nomenclature
- Principles of abbreviation formation from systematic chemical names
- Difference between original drugs and generics
- Rules for writing prescriptions using commercial names
Master the entire topic in the "Latin Language" course
This is a summary. The course covers everything tested in classes and exams.
- Complete study guide on "Trade names of medicinal products" and 2,323 more pages of the subject
- Assignments and quizzes after every topic — just like in a colloquium
- AI tutor answers questions on the topic anytime
- 107 video lessons on the subject
Other topics in the "Dosage Forms" section
Prepared by WhiteCoat Pro faculty in accordance with the medical school curriculum. For educational purposes only.